Unknown

Dataset Information

0

68Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review.


ABSTRACT: Localization of prostate cancer recurrence, particularly in the bones, is a major challenge with standard of care imaging in patients with biochemical recurrence following curatively intended treatment. Gallium-68-labeled prostate specific membrane antigen positron emission tomography/computed tomography (68Ga-PSMA PET/CT) is a novel and promising method for imaging in prostate cancer. The present study reports two cases of patients with prostate cancer with biochemical recurrence, with evidence of bone metastases on 68Ga-PSMA PET/CT images and low prostate specific antigen PSA levels (<2 ng/ml) and PSA doubling time >6 months. The bone metastases were verified by supplementary imaging with 18F-sodium fluoride PET/CT and magnetic resonance imaging as well as biochemical responses to androgen deprivation therapy. Therefore, 68Ga-PSMA PET/CT is promising for the restaging of patients with prostate cancer with biochemical recurrence, including patients with low PSA levels and low PSA kinetics.

SUBMITTER: Petersen LJ 

PROVIDER: S-EPMC5492698 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

<sup>68</sup>Ga-PSMA PET/CT for the detection of bone metastasis in recurrent prostate cancer and a PSA level <2 ng/ml: Two case reports and a literature review.

Petersen Lars J LJ   Nielsen Julie B JB   Dettmann Katja K   Fisker Rune V RV   Haberkorn Uwe U   Stenholt Louise L   Zacho Helle D HD  

Molecular and clinical oncology 20170531 1


Localization of prostate cancer recurrence, particularly in the bones, is a major challenge with standard of care imaging in patients with biochemical recurrence following curatively intended treatment. Gallium-68-labeled prostate specific membrane antigen positron emission tomography/computed tomography (<sup>68</sup>Ga-PSMA PET/CT) is a novel and promising method for imaging in prostate cancer. The present study reports two cases of patients with prostate cancer with biochemical recurrence, wi  ...[more]

Similar Datasets

| S-EPMC5807533 | biostudies-literature
| S-EPMC10250454 | biostudies-literature
| S-EPMC10213584 | biostudies-literature
| S-EPMC9857048 | biostudies-literature
| S-EPMC9035563 | biostudies-literature
| S-EPMC7081247 | biostudies-literature
| S-EPMC10476329 | biostudies-literature
| S-EPMC8076114 | biostudies-literature
| S-EPMC10997563 | biostudies-literature
| S-EPMC7060303 | biostudies-literature